Wednesday, October 08, 2025

From "Out of Stock" to Fulfillment: How Mark Cuban Cost Plus Drug Company's 2023 HealthDyne Deal Improved Drug Distribution

›
Several years ago, I blogged about a PBM-powered coupon-generating app and website operated by WellDyne , which was from one of the smaller ...
Monday, October 06, 2025

After 50 Years with T1D, I Still Have Advocacy Work to Do

›
In July 2026, I'll become eligible for Joslin's Half-Century Medal , awarded to those who have lived with Type 1 diabetes (T1D) for ...
Sunday, September 28, 2025

Dexcom's Management Obscures Receivables, Hides Days Sales Outstanding (DSO), and Spins a Narrative Investors Shouldn't Trust

›
This is certainly a "Business of Diabetes" story. Dexcom Inc., once the undisputed leader in continuous glucose monitoring, now fi...
Sunday, September 14, 2025

On Immunization, Blue & Purple States Declare Independence from Disproven Federal Anti-Vax Policies Imposed by Trump HHS Secretary

›
This was both predictable and inevitable. The United States now finds itself navigating a fractured public health landscape, a direct conseq...
Tuesday, August 19, 2025

Diabetes Mine Innovation Project Study on GLP-1 Therapies and T1D

›
Some of my followers may recall that once upon a time, there was a diabetes blog started by Amy Tenderich which was called "Diabetes M...
Thursday, August 07, 2025

Biocon's Kirsty Becomes Second Insulin Aspart Biosimilar to Receive U.S. FDA Approval

›
Just a few weeks ago, on July 15, 2025, Biocon Biologics announced that the U.S. Food and Drug Administration (FDA) had formally approved it...
Monday, August 04, 2025

Platinum Equity Plans to Reorganize LifeScan Diabetes Testing Business in Chapter 11 Filing

›
As a person living with Type 1 diabetes (T1D) and hypoglycemia unawareness, I rely on traditional fingerstick blood glucose monitoring (BGM)...
1 comment:
Sunday, June 29, 2025

Could There Be Trouble In Civica's Insulin Biosimilar Paradise?

›
It is possible you might not have caught an obscure press release (see the press release at https://www.prnewswire.com/news-releases/bioc...
Wednesday, June 18, 2025

Mark Cuban Cost Plus Drug Company Enters the Telehealth Arena for Generic GLP-1s

›
On June 17, 2025, Mark Cuban Cost Plus Drug Company PBC announced a collaboration with a telehealth company known as 9amHealth (see the pr...